Antidepressants in the treatment of patients with COPD: Possible associations between smoking cigarettes, COPD and depression

Thorax

Volumn 56, Issue 8, 2001, Pages 587-588

  Wagena, E J ^a   Huibers, M J H ^a   Van Schayck, C P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; NORTRIPTYLINE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COMORBIDITY; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG MECHANISM; EDITORIAL; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SMOKING CESSATION;

ANTIDEPRESSIVE AGENTS; BUPROPION; DEPRESSIVE DISORDER; HUMANS; LUNG DISEASES, OBSTRUCTIVE; NORTRIPTYLINE; SMOKING CESSATION;

EID: 0034900548     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.8.587     Document Type: Editorial

References (14)

1. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking
2. A randomized trial of nortriptyline for smoking cessation
3. A comparison of sustained-release bupropion and placebo for smoking cessation
4. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
5. The natural history of chronic airflow obstruction
6. 1. The Lung Health Study
7. Psychosocial concomitants to rehabilitation in chronic obstructive pulmonary disease. Part I. Psychosocial and psychological considerations
8. Chronic obstructive pulmonary disease and symptoms related to depression in elderly persons
9. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease
10. A systematic review of the treatment of depression with antidepressant drugs in patients who also have a physical illness
11. Depression in patients with COPD
12. COPD and depression. Treat them both
13. Major depression and stages of smoking. A longitudinal investigation
14. Smoking and major depression. A causal analysis